Cargando…
A novel mechanism for immune regulation after human lung transplantation
OBJECTIVE: Lung transplantation is therapeutic for end-stage lung disease, but survival is limited due to bronchiolitis obliterans syndrome and restrictive chronic lung allograft dysfunction. We sought a common denominator in lung transplant recipients, analyzing risk factors that trigger immune res...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by The American Association for Thoracic Surgery
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625531/ https://www.ncbi.nlm.nih.gov/pubmed/31288367 http://dx.doi.org/10.1016/j.jtcvs.2018.12.105 |
_version_ | 1783434432744521728 |
---|---|
author | Mohanakumar, Thalachallour Sharma, Monal Bansal, Sandhya Ravichandran, Ranjithkumar Smith, Michael A. Bremner, Ross M. |
author_facet | Mohanakumar, Thalachallour Sharma, Monal Bansal, Sandhya Ravichandran, Ranjithkumar Smith, Michael A. Bremner, Ross M. |
author_sort | Mohanakumar, Thalachallour |
collection | PubMed |
description | OBJECTIVE: Lung transplantation is therapeutic for end-stage lung disease, but survival is limited due to bronchiolitis obliterans syndrome and restrictive chronic lung allograft dysfunction. We sought a common denominator in lung transplant recipients, analyzing risk factors that trigger immune responses that lead to bronchiolitis obliterans syndrome. METHODS: We collected blood from patients who underwent lung transplant at our institution. Exosomes were isolated from the sera of recipients with risk factors for chronic rejection and from stable recipients. Exosomes were analyzed with western blot, using antibodies to lung self-antigens K alpha 1 tubulin and collagen-V, costimulatory molecules (costimulatory molecule 80, costimulatory molecule 86), transcription factors (nuclear factor kappa-light-chain-enhancer of activated B cells, hypoxia-inducible factor 1α, Class II Major Histocompatibility Complex Transactivator), and 20S proteasome. RESULTS: Of the 90 patients included, we identified 5 with grade 3 primary graft dysfunction, 5 without, 15 with respiratory viral infection, 10 with acute rejection, 10 with donor-specific antibodies (DSA), 5 without DSA, and 10 who were stable for exosome isolation. Recipients with grade 3 primary graft dysfunction, respiratory viral infection, acute rejection, and DSA had exosomes containing self-antigens; exosomes from stable recipients did not. Exosomes from recipients with grade 3 primary graft dysfunction, acute rejection, and DSA also demonstrated costimulatory molecule 80, costimulatory molecule 86, major histocompatibility complex class II, transcription factor, and 20S proteasome. CONCLUSIONS: Transplanted lungs with grade 3 primary graft dysfunction, symptomatic respiratory viral infection, acute rejection, and immune responses induce exosomes that contain self-antigens, costimulatory molecules, major histocompatibility complex class II, transcription factors, and 20S proteasome. Release of circulating exosomes post-transplant from the aforementioned stress-inducing insults augment immunity and may play an important role in the pathogenesis of bronchiolitis obliterans syndrome. |
format | Online Article Text |
id | pubmed-6625531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | by The American Association for Thoracic Surgery |
record_format | MEDLINE/PubMed |
spelling | pubmed-66255312020-03-25 A novel mechanism for immune regulation after human lung transplantation Mohanakumar, Thalachallour Sharma, Monal Bansal, Sandhya Ravichandran, Ranjithkumar Smith, Michael A. Bremner, Ross M. J Thorac Cardiovasc Surg Article OBJECTIVE: Lung transplantation is therapeutic for end-stage lung disease, but survival is limited due to bronchiolitis obliterans syndrome and restrictive chronic lung allograft dysfunction. We sought a common denominator in lung transplant recipients, analyzing risk factors that trigger immune responses that lead to bronchiolitis obliterans syndrome. METHODS: We collected blood from patients who underwent lung transplant at our institution. Exosomes were isolated from the sera of recipients with risk factors for chronic rejection and from stable recipients. Exosomes were analyzed with western blot, using antibodies to lung self-antigens K alpha 1 tubulin and collagen-V, costimulatory molecules (costimulatory molecule 80, costimulatory molecule 86), transcription factors (nuclear factor kappa-light-chain-enhancer of activated B cells, hypoxia-inducible factor 1α, Class II Major Histocompatibility Complex Transactivator), and 20S proteasome. RESULTS: Of the 90 patients included, we identified 5 with grade 3 primary graft dysfunction, 5 without, 15 with respiratory viral infection, 10 with acute rejection, 10 with donor-specific antibodies (DSA), 5 without DSA, and 10 who were stable for exosome isolation. Recipients with grade 3 primary graft dysfunction, respiratory viral infection, acute rejection, and DSA had exosomes containing self-antigens; exosomes from stable recipients did not. Exosomes from recipients with grade 3 primary graft dysfunction, acute rejection, and DSA also demonstrated costimulatory molecule 80, costimulatory molecule 86, major histocompatibility complex class II, transcription factor, and 20S proteasome. CONCLUSIONS: Transplanted lungs with grade 3 primary graft dysfunction, symptomatic respiratory viral infection, acute rejection, and immune responses induce exosomes that contain self-antigens, costimulatory molecules, major histocompatibility complex class II, transcription factors, and 20S proteasome. Release of circulating exosomes post-transplant from the aforementioned stress-inducing insults augment immunity and may play an important role in the pathogenesis of bronchiolitis obliterans syndrome. by The American Association for Thoracic Surgery 2019-05 2019-02-12 /pmc/articles/PMC6625531/ /pubmed/31288367 http://dx.doi.org/10.1016/j.jtcvs.2018.12.105 Text en © 2019 by The American Association for Thoracic Surgery. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Mohanakumar, Thalachallour Sharma, Monal Bansal, Sandhya Ravichandran, Ranjithkumar Smith, Michael A. Bremner, Ross M. A novel mechanism for immune regulation after human lung transplantation |
title | A novel mechanism for immune regulation after human lung transplantation |
title_full | A novel mechanism for immune regulation after human lung transplantation |
title_fullStr | A novel mechanism for immune regulation after human lung transplantation |
title_full_unstemmed | A novel mechanism for immune regulation after human lung transplantation |
title_short | A novel mechanism for immune regulation after human lung transplantation |
title_sort | novel mechanism for immune regulation after human lung transplantation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625531/ https://www.ncbi.nlm.nih.gov/pubmed/31288367 http://dx.doi.org/10.1016/j.jtcvs.2018.12.105 |
work_keys_str_mv | AT mohanakumarthalachallour anovelmechanismforimmuneregulationafterhumanlungtransplantation AT sharmamonal anovelmechanismforimmuneregulationafterhumanlungtransplantation AT bansalsandhya anovelmechanismforimmuneregulationafterhumanlungtransplantation AT ravichandranranjithkumar anovelmechanismforimmuneregulationafterhumanlungtransplantation AT smithmichaela anovelmechanismforimmuneregulationafterhumanlungtransplantation AT bremnerrossm anovelmechanismforimmuneregulationafterhumanlungtransplantation AT mohanakumarthalachallour novelmechanismforimmuneregulationafterhumanlungtransplantation AT sharmamonal novelmechanismforimmuneregulationafterhumanlungtransplantation AT bansalsandhya novelmechanismforimmuneregulationafterhumanlungtransplantation AT ravichandranranjithkumar novelmechanismforimmuneregulationafterhumanlungtransplantation AT smithmichaela novelmechanismforimmuneregulationafterhumanlungtransplantation AT bremnerrossm novelmechanismforimmuneregulationafterhumanlungtransplantation |